• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.79% Nasdaq Down 1.55%

    DepoMed Inc. (DEPO)

    -NasdaqGS
    23.36 Down 0.53(2.22%) 4:00PM EDT
    |After Hours : 23.36 0.00 (0.00%) 4:37PM EDT
    Add to Portfolio
    Prev Close:23.89
    Open:23.95
    Bid:23.34 x 100
    Ask:25.18 x 100
    1y Target Est:27.92
    Beta:1.71
    Next Earnings Date:11-May-15DEPO Earnings announcement
    Day's Range:23.21 - 24.14
    52wk Range:9.85 - 28.16
    Volume:1,076,988
    Avg Vol (3m):1,559,640
    Market Cap:1.39B
    P/E (ttm):11.39
    EPS (ttm):2.05
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for DEPO

    Comparison

    Symbol% ChgMkt Cap
    DEPODown 2.22%1.39B
    MRKDown 0.25%171.09B
    PFEDown 0.58%209.51B
    TEVADown 0.76%52.36B

    Key Statistics

    Forward P/E (1 yr):17.43
    P/S (ttm):3.64
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :0.68
    Quarterly EPS Est (Mar-15) :0.01
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):1.17

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Depomed, Inc., a specialty pharmaceutical company, develops products for pain and other central nervous system conditions in the United States. It offers Gralise (gabapentin), an once-daily product for the management of postherpetic neuralgia; CAM... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback